Hint mode is switched on Switch off

BillionToOne, ordinary share
BLLN, US0901681058

Add a stock to WL
Choose all Reset all
BillionToOne, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
BillionToOne Inc is a United States-based precision diagnostics company. The Company provides Quantitative Counting Template (QCT) molecular counter platform, is the only technology platform that can count deoxyribonucleic acid (DNA) molecules to the single-count level and ...
BillionToOne Inc is a United States-based precision diagnostics company. The Company provides Quantitative Counting Template (QCT) molecular counter platform, is the only technology platform that can count deoxyribonucleic acid (DNA) molecules to the single-count level and detect risk for common and severe genetic diseases. The Company’s product UNITY, is a noninvasive prenatal screening that tests fetal cell-free DNA for cystic fibrosis (CF) and spinal muscular atrophy (SMA) through a single sample of the mother's blood.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    BillionToOne, Inc.
  • Industry
    Medical Services

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BLLN
  • Placement
    06.11.2025
  • Lock up period
    180
  • Number of papers
    4,551,100
  • Volume of raised funds
    273.07 mln USD
  • Placement share
    11.33%
  • Final placement price
    60 USD
  • Price change since placement date
    55.65%
  • By capitalization
    2,410.06 mln USD

IFRS/US GAAP reports

2026
I q eng
II q eng
2025
III q eng
Show all Hide

Related Stock indices

Indicators

News

23/06/2026 BillionToOne: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of Registrant, Financial Statements And Exhibits
10/06/2026 BillionToOne: Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
06/05/2026 BillionToOne: Results Of Operations And Financial Condition, Financial Statements And Exhibits
04/03/2026 BillionToOne: Results Of Operations And Financial Condition, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
12/01/2026 BillionToOne: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.